Standardized, risk-adapted induction therapy in kidney transplantation

被引：0
|
作者：
Felix Eisinger
Thomas Mühlbacher
Ario Na
Karina Althaus
Silvio Nadalin
Andreas L. Birkenfeld
Nils Heyne
Martina Guthoff
机构：
[1] University of Tübingen,Department of Diabetology, Endocrinology, Nephrology
[2] University of Tübingen,Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich
[3] German Center for Diabetes Research (DZD e.V.),Department of General
[4] University of Tübingen,, Visceral
[5] University of Tübingen, and Transplant Surgery
来源：
Journal of Nephrology | 2023年 / 36卷 / 7期
关键词：
Kidney transplantation; Induction therapy; Immunological risk; Standard operating procedure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2133 / 2138
页数：5
相关论文
共 50 条
  • [31] Risk-adapted therapy for advanced-stage Hodgkin lymphoma
    Spinner, Michael A.
    Advani, Ranjana H.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 200 - 206
  • [32] Risk-adapted Early Detection
    Riemann, J. F.
    Zeuzem, S.
    [J]. GASTROENTEROLOGE, 2015, 10 (01): : 5 - 6
  • [33] Risk-Adapted Approaches to Therapy for High-Risk Acute Promyelocytic Leukemia
    Ranganathan, Aarati
    Powell, Bayard L.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 : S135 - S138
  • [34] Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation
    Mori, T
    Okamoto, S
    Matsuoka, S
    Yajima, T
    Wakui, M
    Watanabe, R
    Ishida, A
    Iwao, Y
    Mukai, M
    Hibi, T
    Ikeda, Y
    [J]. BONE MARROW TRANSPLANTATION, 2000, 25 (07) : 765 - 769
  • [35] Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation
    T Mori
    S Okamoto
    S Matsuoka
    T Yajima
    M Wakui
    R Watanabe
    A Ishida
    Y Iwao
    M Mukai
    T Hibi
    Y Ikeda
    [J]. Bone Marrow Transplantation, 2000, 25 : 765 - 769
  • [36] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Craig Moskowitz
    [J]. Cancer Chemotherapy and Pharmacology, 2002, 49 : 9 - 12
  • [37] Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation
    Jayakumar, Indira
    Uppuluri, Ramya
    Lakshmanan, Chidhambharam
    Kumar Gowdhaman, Anand
    Vellaichamy Swaminathan, Venkateswaran
    Raj, Revathi
    [J]. PEDIATRIC TRANSPLANTATION, 2021, 25 (05)
  • [38] Risk-adapted strategy for the kidney-sparing management of upper tract tumours
    Thomas Seisen
    Pierre Colin
    Morgan Rouprêt
    [J]. Nature Reviews Urology, 2015, 12 : 155 - 166
  • [39] Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy
    Moskowitz, C
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (Suppl 1) : S9 - S12
  • [40] Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia
    Langerbeins, Petra
    Gross-Ophoff-Mueller, Carolin
    Herling, Carmen D.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (1-2) : 18 - 24
12345